Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Pharmacological and histopathological characterization of a hyperalgesia model induced by freeze lesion

Schmidtko, Achima,1; Burian, Mariaa,1,2; Altis, Kostaa; Hardt, Katjab; Angioni, Carloa; Schmidt, Ronalda; Podda, Mauriziob; Geisslinger, Gerda,*

doi: 10.1016/j.pain.2006.11.002
Articles
Buy

Induction of a freeze lesion in human skin is an experimental model of hyperalgesia that allows assessing the antihyperalgesic effects of traditional non-steroidal anti-inflammatory drugs (NSAIDs). We have investigated whether this model is also sensitive to selective cyclooxygenase (COX)-2 inhibitors and have characterized morphological substrates of the generated hyperalgesia in the skin. In eight healthy subjects, a freeze lesion was induced and mechanical pain thresholds (MPT) were tested for 5 h following administration of the non-selective COX inhibitor diclofenac (75 mg), the COX-2-selective inhibitor parecoxib (40 mg) or placebo in a randomized, double-blind cross-over study. In five additional healthy subjects, biopsies were taken from normal skin and the area of freezing injury. Induction of the freeze lesion resulted in hyperalgesia expressed by a decrease of MPT after 24 h. Diclofenac and parecoxib, but not placebo, statistically significantly elevated MPT. Histochemical and Western blot analyses of skin biopsies revealed a strong upregulation of COX-2, a slight decrease of COX-1 and activation of nuclear factor kappa B (NF-κB) in the area of the freezing injury. These findings indicate that the freeze lesion model is sensitive to NSAIDs including selective COX-2 inhibitors, and that NF-κB-dependent COX-2 upregulation contributes to the hyperalgesia in this model.

apharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Theodor Stern Kai 7, D-60590, Frankfurt/Main, Germany

bDepartment of Dermatology/ZAFES, Johann Wolfgang Goethe-University, Theodor Stern Kai 7, D-60590, Frankfurt/Main, Germany

*Corresponding author. Tel.: +49 69 6301 7619; fax: +49 69 6301 7636.

E-mail: Geisslinger@em.uni-frankfurt.de

1Both authors contributed equally to this work.

E-mail: Geisslinger@em.uni-frankfurt.de

2Present address: Nuvo Research Inc., 7560 Airport Road, Unit 10, Mississauga, Ontario, Canada.

E-mail: Geisslinger@em.uni-frankfurt.de

Submitted July 5, 2006; revised September 12, 2006; accepted November 6, 2006.

© 2007 Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website